| Chapter 1 Executive Summary |
|
| Market Overview |
1-1 |
| Introduction |
1-1 |
| Competitive Analysis |
1-2 |
| Summary of Findings |
1-3 |
| Market Forecasts |
1-3 |
| Market Segment Analysis |
1-5 |
| New Classification |
1-6 |
| Conclusion |
1-7 |
| |
|
| Chapter 2 Total Biosensors Market |
|
| Overview and Definition |
2-1 |
| Overview |
2-1 |
| Definition |
2-1 |
| Analyte |
2-2 |
| Immunoassay |
2-3 |
| Sensor/Transducer |
2-3 |
| Market Engineering Measurements Analysis |
2-3 |
| Industry Challenges |
2-5 |
| Primary Industry Challenges |
2-5 |
| Strict Implementation of Regulatory Provisions Impedes Market Penetration |
2-6 |
| Single Biosensor Platform for Multipurpose Diagnostics Curtails Use |
2-7 |
| Problems in Successful Commercialization of Biosensors Incites Conservative Development Strategies |
2-8 |
| Competition from Non-Biosensor Technologies Hinders Revenue Growth |
2-8 |
| Maturing Biochip Technology Poses Tough Technical Challenges to New Entrants |
2-9 |
| Secondary Industry Challenges |
2-9 |
| Low Rate of Technology Transfer and Lower Level of Development Deters Development |
2-10 |
| Product and Technology Alternatives Curb Market Prospects |
2-10 |
| Restricted Inroads into Newer Areas of Fundamental Research Impedes Newer Applications |
2-11 |
| Clinical Laboratories Dictate Adoption of Point of Care Biosensors in Hospitals |
2-12 |
| Higher Costs per Test in Point-of-Care Market Discourages Utilization |
2-12 |
| Market Dynamics |
2-13 |
| Primary Market Drivers |
2-13 |
| Demand for Multiple Applications Augments Development |
2-14 |
| Consistent Technological Developments Boosts Increased Use |
2-14 |
| Continuous Increase in the Aged Population Inspires Higher Demand |
2-15 |
| Increase in Environmental Awareness Creates Demand for Newer Biosensors |
2-15 |
| Collaborative Research Efforts between Industry and University Laboratories Cultivates Demand |
2-16 |
| Secondary Market Drivers |
2-17 |
| Intensive Research by Universities Boosts Application Span |
2-17 |
| The Development of Nano Sensor Encourages Miniaturization |
2-18 |
| Enhanced Focus on Security Incites Demand |
2-19 |
| Increased Emphasis on Health Wellness Cultivates Use |
2-20 |
| Expanding Demand from Point of Care Market Bolsters Technology Improvements |
2-20 |
| Primary Market Restraints |
2-20 |
| High Price Levels Hinders Usage |
2-22 |
| Decreasing Number of Hospitals Limits Usage |
2-22 |
| Stagnant Growth of Point-of-Care Market Curtails Demand |
2-23 |
| High Research and Development Expenses Retards Innovation |
2-23 |
| Preservation of Biosensors Specially in Harsh Environment Limits Large-Scale Deployment |
2-24 |
| Alternative Technologies Restrict Demand for Newer Biosensors |
2-24 |
| Secondary Market Restraints |
2-25 |
| Long Time Lag between Academic Research and Commercialization |
2-25 |
| Low Rate of Technology Transfer from Laboratory to Commercial Enterprises |
2-25 |
| Increased Competition Restricts Revenues |
2-26 |
| Technology Primer and Biosensing Process |
2-26 |
| Biosensors Basics |
2-26 |
| Glucose Biosensing |
2-27 |
| Urea Biosensing |
2-27 |
| The Bananatrode |
2-27 |
| Biosensing Process |
2-28 |
| Biosensor Components |
2-28 |
| Biomolecule |
2-29 |
| Biosensing Process |
2-29 |
| Biosensor Designs |
2-30 |
| Biological Element |
2-32 |
| Tissue Materials |
2-33 |
| Microorganisms |
2-33 |
| Mitochondria |
2-34 |
| Nucleic Acid |
2-34 |
| Receptors |
2-34 |
| Transducer Technology for Biosensor |
2-34 |
| Potentiometry |
2-35 |
| Voltametry |
2-35 |
| Conductometry |
2-35 |
| Field Effect Transistors (FET) |
2-36 |
| Optical Methods |
2-36 |
| Piezoelectric—Crystals |
2-36 |
| Biosensor Technology Types |
2-36 |
| Invasive |
2-37 |
| Noninvasive |
2-37 |
| Biosensor System Attributes |
2-37 |
| Performance Factors |
2-37 |
| Selectivity |
2-38 |
| Range and Linear Range |
2-38 |
| Reproducibility |
2-38 |
| Response Time |
2-39 |
| Life Time limits |
2-39 |
| Technology Trends and Limitations |
2-39 |
| Technology Trends |
2-39 |
| Electrochemical Biosensors |
2-41 |
| Piezoelectric (Quartz/Crystal) Biosensors |
2-41 |
| Opto—electronic devices Biosensors |
2-41 |
| New Classification |
2-42 |
| Biosensor |
2-42 |
| Cell on Chip Biosensor Concept |
2-43 |
| Microfluidics Systems for Drug Discovery and Lead Optimization—The Netherlands |
2-43 |
| Cell-on-Chip Biosensor |
2-44 |
| Integrated Microfluidic Bench Technologies |
2-44 |
| Market Forecasts |
2-45 |
| Total Revenue Forecasts |
2-45 |
| Revenue Forecasts by Vertical Market |
2-46 |
| Research Laboratories |
2-49 |
| Home Diagnostics |
2-49 |
| Process Industries |
2-50 |
| Environmental Monitoring |
2-50 |
| Security and Biodefense |
2-51 |
| Revenue Forecasts by Geographic Markets |
2-51 |
| North America |
2-53 |
| Europe |
2-57 |
| Asia Pacific |
2-60 |
| Rest-of-World |
2-63 |
| Market Trends |
2-66 |
| Distribution Trends |
2-66 |
| Direct Sales |
2-68 |
| OEM/System Integrators |
2-68 |
| Distributors |
2-69 |
| Institutional Buyers |
2-69 |
| Sales through Web (Online Sales) |
2-70 |
| Pricing Trends |
2-70 |
| Competitive Analysis |
2-71 |
| Competitive Structure |
2-71 |
| Mergers Acquisitions and Alliances |
2-72 |
| Joint Venture |
2-73 |
| Collaboration |
2-73 |
| Acquisition |
2-73 |
| Exmovere LLC |
2-74 |
| Biosensor Venture Capital Investments |
2-74 |
| Market Share Analysis |
2-75 |
| Total Biosensors Market |
2-75 |
| Research Laboratories Biosensors Market |
2-79 |
| Home Diagnostic Biosensors Market |
2-80 |
| Point-of-Care Biosensors Market |
2-81 |
| Process Industries Biosensors Market |
2-82 |
| Environmental Monitoring Biosensors Market |
2-83 |
| Security and Biodefense Biosensors Market |
2-84 |
| |
|
| Chapter 3 Research Laboratories Biosensors Market |
|
| Overview and Definition |
3-1 |
| Overview |
3-1 |
| Definition |
3-2 |
| Market Engineering Measurement Analysis |
3-2 |
| Market Forecasts |
3-4 |
| Total Revenue Forecasts |
3-4 |
| Revenues by Product Type |
3-5 |
| Market Revenues by Biological Probes |
3-8 |
| Revenues by Research Type |
3-12 |
| Revenue Forecasts by Geographic Region |
3-14 |
| North America |
3-16 |
| Europe |
3-16 |
| Asia Pacific |
3-17 |
| Rest-of-World |
3-17 |
| Technology Trends and Competitive Analysis |
3-18 |
| Technology Trends |
3-18 |
| Biosensors for Detection of Large Molecules |
3-18 |
| Neural Networks |
3-18 |
| Novel Biosensor |
3-18 |
| Use of Position Sensing Technology |
3-19 |
| Competitive Structure |
3-20 |
| Market Trends |
3-21 |
| Distribution Trends |
3-21 |
| Direct Sales Approach |
3-22 |
| Institutional Buyers |
3-22 |
| Web Sales |
3-23 |
| Pricing Analysis |
3-23 |
| |
|
| Chapter 4 Home Diagnostics Biosensors Market |
|
| Overview and Definition |
4-1 |
| Overview |
4-1 |
| Definition |
4-1 |
| Market Engineering Measurement Analysis |
4-2 |
| Market Forecasts |
4-3 |
| Total Market Forecasts |
4-3 |
| Revenue Forecasts by Product Type |
4-5 |
| Glucose Meters |
4-7 |
| Coagulation Monitors |
4-8 |
| Cholesterol Monitoring Meters |
4-8 |
| Others |
4-9 |
| Revenue Forecasts by Geographic Region |
4-9 |
| North America |
4-12 |
| Europe |
4-12 |
| Asia Pacific |
4-13 |
| Rest-of-World |
4-14 |
| Technology Trends and Competitive Analysis |
4-14 |
| Technology Trends |
4-14 |
| GPS-based Sensor Device for Health Monitoring by Exmovere—USA |
4-15 |
| Sathyabama University—India |
4-15 |
| Lab-on-Chip |
4-16 |
| Biosensors—Advancements in Lab-on-Chip and Microfluidics Technologies |
|
| for Drug Discovery and Clinical Diagnostics |
4-16 |
| Evaluating Efficiency of Various Methods for the Lysis of Cells in Lab-on-Chip Systems |
4-17 |
| Competitive Structure |
4-18 |
| Market Trends |
4-19 |
| Distribution Trends |
4-19 |
| Direct Sales |
4-20 |
| Retailers |
4-20 |
| Distributors |
4-20 |
| Institutional Buyers |
4-21 |
| Sales through Web |
4-21 |
| Pricing Analysis |
4-21 |
| |
|
| Chapter 5 Point-of-Care Biosensors Market |
|
| Overview and Definition |
5-1 |
| Overview |
5-1 |
| Definition |
5-1 |
| Market Engineering Measurement Analysis |
5-2 |
| Market Forecasts |
5-3 |
| Total Market Forecasts |
5-3 |
| Revenues by Application Type |
5-5 |
| Revenue Forecasts by Product Type |
5-8 |
| Glucose Testing |
5-11 |
| A1C Testing |
5-12 |
| Cholesterol Testing |
5-12 |
| Drugs of Abuse Testing |
5-12 |
| Infectious Disease Testing |
5-13 |
| Pregnancy Testing |
5-13 |
| Hematology Testing |
5-14 |
| Coagulation Testing |
5-14 |
| Cardiac Biomarkers Testing |
5-15 |
| Blood Gas and Electrolyte Testing |
5-15 |
| Revenues by Geographic Region |
5-15 |
| North America |
5-18 |
| Europe |
5-18 |
| Asia Pacific |
5-18 |
| Rest-of-World |
5-18 |
| Technology Trends and Competitive Analysis |
5-19 |
| Non Invasive and Implantable Biosensor Technology Innovations |
5-19 |
| Noninvasive Continuous Glucose Monitoring Device |
5-19 |
| Innovative, Implantable Glucose Biosensor based on Proprietary Hydrogel Technology |
5-20 |
| Noninvasive Glucose Biosensing through a Three-way Technology Amalgamation |
5-20 |
| Smart and Multipurpose Biosensors Technology Platforms |
5-21 |
| Biosensors Platform for Multipurpose Diagnostics |
5-21 |
| Smart Diagnostic Biosensors Total Blood Analysis Card Platform |
5-22 |
| Biosensors for Arterial Stiffness Index Detection |
5-22 |
| Hybrid Biosensing Technologies |
5-23 |
| Hybrid Biosensing—Wavesense Technology with Dynamic Electrochemistry for Diabetics |
5-23 |
| Unique Coulometry Technology for Abbott's FreeStyle Blood Glucose Monitoring System |
5-24 |
| RF Spectroscopy Facilitates Real Time Breast Cancer Diagnosis |
5-25 |
| Multiple Test Lab-on-Card Platform |
5-26 |
| Point-of-care Testing through Credit Card—sized Microfluidic Devices—Canada |
5-26 |
| Point-of-Care Application Advantages |
5-27 |
| Competitive Structure |
5-28 |
| Market Trends |
5-29 |
| Distribution Trends |
5-29 |
| Direct Sales Approach |
5-30 |
| Institutional Buyers |
5-30 |
| Distributors |
5-31 |
| Pricing Analysis |
5-31 |
| |
|
| Chapter 6 Process Industries Biosensors Market |
|
| Overview and Definition |
6-1 |
| Overview |
6-1 |
| Definition |
6-1 |
| Market Engineering Measurement Analysis |
6-2 |
| Market Forecasts |
6-3 |
| Total Revenue Forecasts |
6-3 |
| Revenue by Application |
6-5 |
| End-user Process Industries |
6-5 |
| Types of Applications |
6-5 |
| Revenue Forecasts by Product Type |
6-8 |
| Product Types |
6-8 |
| Revenue Forecasts by Geographic Region |
6-11 |
| North America |
6-14 |
| Europe |
6-14 |
| Asia Pacific |
6-15 |
| Rest-of-World |
6-15 |
| Technology Trends and Competitive Analysis |
6-16 |
| Technology Trends |
6-16 |
| Bacteria Magnets |
6-16 |
| Immunomagnetic Beads |
6-17 |
| Breaking Meat Matrix |
6-17 |
| Reducing Manufacturing Costs While Increasing Optical Sensitivity |
6-18 |
| Competitive Structure |
6-19 |
| Market Trends |
6-20 |
| Distribution Trends |
6-20 |
| Direct Sales Approach |
6-20 |
| Distributors |
6-21 |
| Technical Service Companies |
6-21 |
| Pricing Analysis |
6-21 |
| |
|
| Chapter 7 Environmental Monitoring Biosensors Market |
|
| Overview and Definition |
7-1 |
| Overview |
7-1 |
| Definition |
7-1 |
| Market Engineering Measurement Analysis |
7-2 |
| Market Forecasts |
7-3 |
| Market Forecasts |
7-3 |
| Revenues by Product Type |
7-5 |
| BOD Biosensors |
7-8 |
| Revenue Forecasts by Geographic Region |
7-10 |
| North America |
7-13 |
| Europe |
7-13 |
| Asia Pacific |
7-14 |
| Rest-of-World |
7-14 |
| Technology Trends and Competitive Analysis |
7-14 |
| Technology Trends |
7-14 |
| Biosensor Quartz Crystal Microbalance Sensor Process |
7-15 |
| Mapping Toxins |
7-15 |
| E Coli Detection |
7-16 |
| Microbiological Site Assessment Technology (MSAT) |
7-16 |
| Sea Water Contamination |
7-17 |
| Treating Industrial Pollutants in Paint Making |
7-17 |
| Competitive Structure |
7-18 |
| Market Trends |
7-19 |
| Distribution Trends |
7-19 |
| Direct Sales |
7-20 |
| Distributors |
7-20 |
| Environmental Agencies and Government Departments |
7-21 |
| Institutional Buyers |
7-21 |
| Price Analysis |
7-21 |
| |
|
| Chapter 8 Security and Biodefense Biosensors Market |
|
| Overview and Definition |
8-1 |
| Overview of Biodefense Application |
8-1 |
| Definition |
8-2 |
| Bioterrorism Act |
8-3 |
| Market Engineering Measurement Analysis |
8-4 |
| Market Forecasts |
8-5 |
| Market Forecasts |
8-5 |
| Revenue Forecasts by Application |
8-8 |
| Biological Detection |
8-11 |
| Drug and Narcotic Detection |
8-11 |
| Explosive Detection (Chemical and Explosive Substance Detection) |
8-12 |
| Revenues by Product Type |
8-13 |
| Revenues by Geographic Region |
8-18 |
| North America |
8-20 |
| Europe |
8-21 |
| Asia Pacific |
8-21 |
| Rest of World |
8-21 |
| Technology Trends and Competitive Analysis |
8-22 |
| Technology Trends |
8-22 |
| Polymerase Chain Reaction (PCR) |
8-22 |
| Multi-application Biosensor Platforms |
8-22 |
| Bio-cells as Detection Sensor |
8-23 |
| Carbon Nano-Tube Innovation |
8-24 |
| Competitive Structure |
8-25 |
| Market Trends |
8-26 |
| Distribution Structure |
8-26 |
| System Integrators and Patent Holders |
8-27 |
| Distributors |
8-27 |
| Government Security Agencies and Defense Departments |
8-27 |
| Institutional Buyers |
8-27 |
| Price Trends |
8-28 |
| |
|
| Chapter 9 Appendix |
|
| DSD |
9-1 |
| Number of Hospitals |
9-1 |
| Number of Hospital Beds |
9-3 |
| Female Population 65 Plus |
9-6 |
| Male Population 65 Plus |
9-8 |
| Total Population |
9-10 |
| Environmental Protection Expenditure |
9-12 |
| Total Water Consumption |
9-14 |
| Frozen Food Production |
9-17 |
| Consumer Expenditures on Food Beverages and Tobacco |
9-19 |
| Prevalence of Diabetes |
9-22 |
| Prevalence Percent Diabetes |
9-24 |
| Government Healthcare Expenditure |
9-26 |
| Private Healthcare Expenditure |
9-29 |
| Total Healthcare Expenditures |
9-31 |
| Percapita Healthcare Expenditures |
9-33 |
| Total Fertility Rate |
9-35 |
| Nominal GDP |
9-38 |
报告纸介版价格（￥）
报告出版日期
msn咨询